After early hiccups in manufacturing, Adverum outlines plans for commercial gene therapy plant in North Carolina hub

SourceEndpints News
Date Published01/08/2021
Author NameConner Mitchell
Mentions specific company case(s) of reshoring, kept from offshoring, or transplantYes

Additional Reshoring Information:

Company/Division name Adverum
Type of work Manufacturing
Reshoring category:Reshoring
Year reshoring announced:2021
Year reshoring implemented or to be implemented:2023
Domestically, the work will be done:In-house
Capital investment ($):80
City reshored to:Triangle Park
State(s) reshored to:NC
If relevant, work nearshored to:-
Product(s) reshoredADVM-022
What domestic positive factors made reshoring more attractive?Eco-system synergies, Government Incentives, Skilled workforce availability/training
Government Incentive dollar amount:$9 million
Find Reshoring Articles